Age-Dependent Alterations in the Interactions of NF-κB and N-myc with GLT-1/EAAT2 Promoter in the Pericontusional Cortex of Mice Subjected to Traumatic Brain Injury

Molecular Neurobiology

Volumn 53, Issue 5, 2016, Pages 3377-3388

  Gupta, Rajaneesh K ^a   Prasad, S ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Aging; GLT 1 EAAT2; N myc; NF B; Traumatic brain injury

Indexed keywords

AQUAPORIN 4; EXCITATORY AMINO ACID TRANSPORTER 2; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYC PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VESICULAR GLUTAMATE TRANSPORTER 1; MESSENGER RNA; MYCN PROTEIN, MOUSE; N MYC PROTO ONCOGENE PROTEIN; PROTEIN BINDING; TUMOR NECROSIS FACTOR;

ADULT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DISEASE ACTIVITY; GEL MOBILITY SHIFT ASSAY; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRAUMATIC BRAIN INJURY; AGING; ANIMAL; GENETICS; METABOLISM; PATHOLOGY; PROMOTER REGION;

AGING; ANIMALS; AQUAPORIN 4; BRAIN INJURIES, TRAUMATIC; CEREBRAL CORTEX; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXCITATORY AMINO ACID TRANSPORTER 2; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; MICE; N-MYC PROTO-ONCOGENE PROTEIN; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84931048798     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9287-y     Document Type: Article

References (45)

1. Prins M, Greco T, Alexander D, Giza CC (2013) The pathophysiology of traumatic brain injury at a glance. Dis Model Mech. doi:10.1242/dmm.011585
2. Sharp DJ, Scott G, Leech R (2014) Network dysfunction after traumatic brain injury. Nat Rev Neurol. doi:10.1038/nrneurol.2014.15
3. Vincenta AS, Roebuck-Spencera TM, Cernich A (2014) Cognitive changes and dementia risk after traumatic brain injury: implications for aging military personnel. Alzheimers Dement 10:S174–S187
4. Goleburn CR, Golden CJ (2001) Traumatic brain injury outcome in older adults: a critical review of the literature. J Clin Geropsychol 7:161–187
5. Thompson HJ, McCormick WC, Kagan SH (2006) Traumatic brain injury in older adults: epidemiology, outcomes, and future implications. J Am Geriatr Soc 54:1590–1595
6. Szatkowski M, Attwell D (1994) Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci 17:359–365
7. Kanai Y, Nussberger S, Romero MF, Boron WF, Hebert SC, Hediger MA (1995) Electrogenic properties of the epithelial and neuronal high affinity glutamate transporter. J Biol Chem 270:16561–16568
8. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kunci RW, Kanai Y, Hediger MA et al (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675–686
9. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T et al (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1/EAAT2/ EAAT2. Science 276:1699–1702
10. Li S, Mallory M, Alford M, Tanaka S, Masliah E (1997) Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 56:901–911
11. Trotti D, Aoki M, Pasinelli P, Berger UV, Danbolt NC, Brown RHJ, Hediger MA (2001) Amyotrophic lateral sclerosis-linked glutamate transporter mutant has impaired glutamate clearance capacity. J Biol Chem 276:576–582
12. Gupta RK, Prasad S (2013) Early down regulation of the glial Kir4.1 and GLT-1 expression in pericontusional cortex of the old male mice subjected to traumatic brain injury. Biogerontology 14:531–541
13. Gupta RK, Prasad S (2014) Differential regulation of GLT-1/EAAT2/ gene expression by NF-κB and N-myc in male mouse brain during postnatal development. Neurochem Res 39:150–160
14. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D (2003) NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 6:1072–1078
15. Memet S (2006) NF-kappaB functions in the nervous system: from development to disease. Biochem Pharmacol 72:1180–1195
16. Perez-Otano I, McMillian MK, Chen J, Bing G, Hong JS, Pennypacker KR (1996) Induction of NF-kB-like transcription factors in brain areas susceptible to kainate toxicity. Glia 16:306–315
17. Prasad AV, Webster HP, Joseph SA (1994) Nuclear factor-kB in rat brain: enhanced DNA-binding activity following convulsant-induced seizures. Neurosci Lett 170:145–148
18. Wei HY, Ma X (2014) Tamoxifen reduces infiltration of inflammatory cells, apoptosis and inhibits IKK/NF-kB pathway after spinal cord injury in rats. Neurol Sci 35:1763–1768
19. Terai K, Natsuo A, McGeer EG, McGeer PL (1996) Enhancement of immunoreactivity for NF-kB in human infarctions. Brain Res 739:343–349
20. Rattner A, Korner M, Walker MD, Citri Y (1993) NF-kappa B activates the HIV promoter in neurons. EMBO J 12:4261–4267
21. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C (1997) Transcription factor NFkappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A 94:2642–2647
22. Gveric D, Kaltschmidt C, Cuzner ML, Newcombe J (1998) Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions. J Neuropathol Exp Neurol 57(2):168–178
23. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y et al (1997) Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci U S A 94(14):7531–7536
24. Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10:405–455
25. Meyer M, Schreck R, Baeuerle PA (1993) H2O2 and antioxidants have opposite effects on activation of NF-kB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12:2005–2015
26. Pahl HL, Baeuerle PA (1997) The ER-overload response: activation of NF-kappa B. Trends Biochem Sci 22:63–67
27. Guerrini L, Molteni A, Wirth T, Kistler B, Blasi F (1997) Glutamate dependent activation of NFkappaB during mouse cerebellum development. J Neurosci 17:6057–6063
28. Timaru-Kast R, Luh C, Gotthardt P, Huang C, Schäfer MK, Engelhard K, Thal SC (2012) Influence of age on brain edema formation, secondary brain damage and inflammatory response after brain trauma in mice. PLoS One 7(8):e43829
29. Krohn K, Rozovsky I, Wals P, Teter B, Anderson CP, Finch CE (1999) Glial fibrillary acidic protein transcription responses to transforming growth factor-beta1 and interleukin-1beta are mediated by a nuclear factor-1-like site in the near-upstream promoter. J Neurochem 72(4):1353–1361
30. Ito H, Yamamoto N, Arima H, Hirate H, Morishima T, Umenishi F, Tada T, Asai K et al (2006) Interleukin-1beta induces the expression of aquaporin-4 through a nuclear factor-kappaB pathway in rat astrocytes. J Neurochem 99(1):107–118
31. deVries HE, Blom-Roosemalen MCM, van Oosten M, de Boer AG, van Berkel TJC, Breimer DD, Kuiper J (1996) The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 64:37–43
32. Yang K, Mu XS, Hayes RL (1995) Increased cortical nuclear factor-kappa B (NF-kappa B) DNA binding activity after traumatic brain injury in rats. Neurosci Lett 197:101–110
33. Guney I, Wu S, Sedivy JM (2006) Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a). Proc Natl Acad Sci U S A 103:3645–3650
34. Knoepfler PS, Cheng PF, Eisenman RN (2002) N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev 16(20):2699–2712
35. Grandori C, Wu KJ, Fernandez P, Ngouenet C, Grim J, Clurman BE, Moser MJ, Oshima J et al (2003) Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev 17:1569–1574
36. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R (1999) Direct activation of TERT transcription by c-MYC. Nat Genet 21(2):220–224
37. Sitcheran R, Gupta P, Fisher PB, Baldwin AS (2005) Positive and negative regulation of EAAT2 by NF-κB: a role for N-myc in TNFa-controlled repression. EMBO J 24:510–520
38. Gupta RK, Kanungo M (2013) Glial molecular alterations with mouse brain development and aging: up-regulation of the Kir4.1 and aquaporin-4. Age (Dordr) 35:59–67
39. Verma P, Singh P, Gandhi BS (2013) Prophylactic efficacy of Bacopa monnieri on decabromodiphenyl ether (PBDE-209)-induced alterations in oxidative status and spatial memory in mice. Asian J Pharm Clin Res 6(3):242–247
40. Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami E (1996) An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma 13:557–568
41. Gordon MN, Schreier WA, Ou X, Holcomb LA, Morgan DG (1997) Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat. J Comp Neurol 388:106–119
42. Topp KS, Faddis BT, Vijayan VK (1989) Trauma-induced proliferation of astrocytes in the brains of young and aged rats. Glia 2:201–211
43. Beni-Adani L, Gozes I, Cohen Y, Assaf Y, Steingart RA, Brenneman DE, Eizenberg O, Trembolver V et al (2001) A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J Pharmacol Exp Ther 296:57–63
44. Ferrer I, Blanco R (2000) N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. Brain Res Mol Brain Res 77:270–276
45. Chapman NR, Webster GA, Gillespie PJ, Wilson BJ, Crouch DH, Perkins ND (2002) A novel form of the RelA nuclear factor kappaB subunit is induced by and forms a complex with the proto-oncogene c-Myc. Biochem J 366(Pt 2):459–469